MyD88 is required for protection from lethal infection with a mouse-adapted SARS-CoV.
Identifieur interne : 001995 ( PubMed/Curation ); précédent : 001994; suivant : 001996MyD88 is required for protection from lethal infection with a mouse-adapted SARS-CoV.
Auteurs : Timothy Sheahan [États-Unis] ; Thomas E. Morrison ; William Funkhouser ; Satoshi Uematsu ; Shizou Akira ; Ralph S. Baric ; Mark T. HeiseSource :
- PLoS pathogens [ 1553-7374 ] ; 2008.
Descripteurs français
- KwdFr :
- Animaux, Charge virale, Culture virale, Cytokines (immunologie), Cytokines (métabolisme), Expression des gènes (immunologie), Facteur de différenciation myéloïde-88 (génétique), Facteur de différenciation myéloïde-88 (métabolisme), Immunité innée, Macrophages (immunologie), Modèles animaux de maladie humaine, Monocytes (immunologie), Poumon (anatomopathologie), Poumon (immunologie), Poumon (virologie), Récepteurs CCR (immunologie), Récepteurs CCR (métabolisme), Réplication virale, Souris, Souris de lignée BALB C, Souris knockout, Statistique non paramétrique, Syndrome respiratoire aigu sévère (immunologie), Syndrome respiratoire aigu sévère (mortalité), Syndrome respiratoire aigu sévère (virologie), Transduction du signal, Virus du SRAS (génétique), Virus du SRAS (pathogénicité), Virus du SRAS (physiologie).
- MESH :
- anatomopathologie : Poumon.
- génétique : Facteur de différenciation myéloïde-88, Virus du SRAS.
- immunologie : Cytokines, Expression des gènes, Macrophages, Monocytes, Poumon, Récepteurs CCR, Syndrome respiratoire aigu sévère.
- mortalité : Syndrome respiratoire aigu sévère.
- métabolisme : Cytokines, Facteur de différenciation myéloïde-88, Récepteurs CCR.
- pathogénicité : Virus du SRAS.
- physiologie : Virus du SRAS.
- virologie : Poumon, Syndrome respiratoire aigu sévère.
- Animaux, Charge virale, Culture virale, Immunité innée, Modèles animaux de maladie humaine, Réplication virale, Souris, Souris de lignée BALB C, Souris knockout, Statistique non paramétrique, Transduction du signal.
English descriptors
- KwdEn :
- Animals, Cytokines (immunology), Cytokines (metabolism), Disease Models, Animal, Gene Expression (immunology), Immunity, Innate, Lung (immunology), Lung (pathology), Lung (virology), Macrophages (immunology), Mice, Mice, Inbred BALB C, Mice, Knockout, Monocytes (immunology), Myeloid Differentiation Factor 88 (genetics), Myeloid Differentiation Factor 88 (metabolism), Receptors, CCR (immunology), Receptors, CCR (metabolism), SARS Virus (genetics), SARS Virus (pathogenicity), SARS Virus (physiology), Severe Acute Respiratory Syndrome (immunology), Severe Acute Respiratory Syndrome (mortality), Severe Acute Respiratory Syndrome (virology), Signal Transduction, Statistics, Nonparametric, Viral Load, Virus Cultivation, Virus Replication.
- MESH :
- chemical , genetics : Myeloid Differentiation Factor 88.
- chemical , immunology : Cytokines, Receptors, CCR.
- chemical , metabolism : Cytokines, Myeloid Differentiation Factor 88, Receptors, CCR.
- genetics : SARS Virus.
- immunology : Gene Expression, Lung, Macrophages, Monocytes, Severe Acute Respiratory Syndrome.
- mortality : Severe Acute Respiratory Syndrome.
- pathogenicity : SARS Virus.
- pathology : Lung.
- physiology : SARS Virus.
- virology : Lung, Severe Acute Respiratory Syndrome.
- Animals, Disease Models, Animal, Immunity, Innate, Mice, Mice, Inbred BALB C, Mice, Knockout, Signal Transduction, Statistics, Nonparametric, Viral Load, Virus Cultivation, Virus Replication.
Abstract
A novel human coronavirus, SARS-CoV, emerged suddenly in 2003, causing approximately 8000 human cases and more than 700 deaths worldwide. Since most animal models fail to faithfully recapitulate the clinical course of SARS-CoV in humans, the virus and host factors that mediate disease pathogenesis remain unclear. Recently, our laboratory and others developed a recombinant mouse-adapted SARS-CoV (rMA15) that was lethal in BALB/c mice. In contrast, intranasal infection of young 10-week-old C57BL/6 mice with rMA15 results in a nonlethal infection characterized by high titer replication within the lungs, lung inflammation, destruction of lung tissue, and loss of body weight, thus providing a useful model to identify host mediators of protection. Here, we report that mice deficient in MyD88 (MyD88(-/-)), an adapter protein that mediates Toll-like receptor (TLR), IL-1R, and IL-18R signaling, are far more susceptible to rMA15 infection. The genetic absence of MyD88 resulted in enhanced pulmonary pathology and greater than 90% mortality by day 6 post-infection. MyD88(-/-) mice had significantly higher viral loads in lung tissue throughout the course of infection. Despite increased viral loads, the expression of multiple proinflammatory cytokines and chemokines within lung tissue and recruitment of inflammatory monocytes/macrophages to the lung was severely impaired in MyD88(-/-) mice compared to wild-type mice. Furthermore, mice deficient in chemokine receptors that contribute to monocyte recruitment to the lung were more susceptible to rMA15-induced disease and exhibited severe lung pathology similar to that seen in MyD88(-/-)mice. These data suggest that MyD88-mediated innate immune signaling and inflammatory cell recruitment to the lung are required for protection from lethal rMA15 infection.
DOI: 10.1371/journal.ppat.1000240
PubMed: 19079579
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: Pour aller vers cette notice dans l'étape Curation :001995
Links to Exploration step
pubmed:19079579Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">MyD88 is required for protection from lethal infection with a mouse-adapted SARS-CoV.</title><author><name sortKey="Sheahan, Timothy" sort="Sheahan, Timothy" uniqKey="Sheahan T" first="Timothy" last="Sheahan">Timothy Sheahan</name><affiliation wicri:level="1"><nlm:affiliation>Department of Microbiology and Immunology, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Department of Microbiology and Immunology, University of North Carolina at Chapel Hill, Chapel Hill, NC</wicri:regionArea></affiliation></author><author><name sortKey="Morrison, Thomas E" sort="Morrison, Thomas E" uniqKey="Morrison T" first="Thomas E" last="Morrison">Thomas E. Morrison</name></author><author><name sortKey="Funkhouser, William" sort="Funkhouser, William" uniqKey="Funkhouser W" first="William" last="Funkhouser">William Funkhouser</name></author><author><name sortKey="Uematsu, Satoshi" sort="Uematsu, Satoshi" uniqKey="Uematsu S" first="Satoshi" last="Uematsu">Satoshi Uematsu</name></author><author><name sortKey="Akira, Shizou" sort="Akira, Shizou" uniqKey="Akira S" first="Shizou" last="Akira">Shizou Akira</name></author><author><name sortKey="Baric, Ralph S" sort="Baric, Ralph S" uniqKey="Baric R" first="Ralph S" last="Baric">Ralph S. Baric</name></author><author><name sortKey="Heise, Mark T" sort="Heise, Mark T" uniqKey="Heise M" first="Mark T" last="Heise">Mark T. Heise</name></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2008">2008</date><idno type="RBID">pubmed:19079579</idno><idno type="pmid">19079579</idno><idno type="doi">10.1371/journal.ppat.1000240</idno><idno type="wicri:Area/PubMed/Corpus">001995</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">001995</idno><idno type="wicri:Area/PubMed/Curation">001995</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">001995</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">MyD88 is required for protection from lethal infection with a mouse-adapted SARS-CoV.</title><author><name sortKey="Sheahan, Timothy" sort="Sheahan, Timothy" uniqKey="Sheahan T" first="Timothy" last="Sheahan">Timothy Sheahan</name><affiliation wicri:level="1"><nlm:affiliation>Department of Microbiology and Immunology, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Department of Microbiology and Immunology, University of North Carolina at Chapel Hill, Chapel Hill, NC</wicri:regionArea></affiliation></author><author><name sortKey="Morrison, Thomas E" sort="Morrison, Thomas E" uniqKey="Morrison T" first="Thomas E" last="Morrison">Thomas E. Morrison</name></author><author><name sortKey="Funkhouser, William" sort="Funkhouser, William" uniqKey="Funkhouser W" first="William" last="Funkhouser">William Funkhouser</name></author><author><name sortKey="Uematsu, Satoshi" sort="Uematsu, Satoshi" uniqKey="Uematsu S" first="Satoshi" last="Uematsu">Satoshi Uematsu</name></author><author><name sortKey="Akira, Shizou" sort="Akira, Shizou" uniqKey="Akira S" first="Shizou" last="Akira">Shizou Akira</name></author><author><name sortKey="Baric, Ralph S" sort="Baric, Ralph S" uniqKey="Baric R" first="Ralph S" last="Baric">Ralph S. Baric</name></author><author><name sortKey="Heise, Mark T" sort="Heise, Mark T" uniqKey="Heise M" first="Mark T" last="Heise">Mark T. Heise</name></author></analytic><series><title level="j">PLoS pathogens</title><idno type="eISSN">1553-7374</idno><imprint><date when="2008" type="published">2008</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Animals</term><term>Cytokines (immunology)</term><term>Cytokines (metabolism)</term><term>Disease Models, Animal</term><term>Gene Expression (immunology)</term><term>Immunity, Innate</term><term>Lung (immunology)</term><term>Lung (pathology)</term><term>Lung (virology)</term><term>Macrophages (immunology)</term><term>Mice</term><term>Mice, Inbred BALB C</term><term>Mice, Knockout</term><term>Monocytes (immunology)</term><term>Myeloid Differentiation Factor 88 (genetics)</term><term>Myeloid Differentiation Factor 88 (metabolism)</term><term>Receptors, CCR (immunology)</term><term>Receptors, CCR (metabolism)</term><term>SARS Virus (genetics)</term><term>SARS Virus (pathogenicity)</term><term>SARS Virus (physiology)</term><term>Severe Acute Respiratory Syndrome (immunology)</term><term>Severe Acute Respiratory Syndrome (mortality)</term><term>Severe Acute Respiratory Syndrome (virology)</term><term>Signal Transduction</term><term>Statistics, Nonparametric</term><term>Viral Load</term><term>Virus Cultivation</term><term>Virus Replication</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Animaux</term><term>Charge virale</term><term>Culture virale</term><term>Cytokines (immunologie)</term><term>Cytokines (métabolisme)</term><term>Expression des gènes (immunologie)</term><term>Facteur de différenciation myéloïde-88 (génétique)</term><term>Facteur de différenciation myéloïde-88 (métabolisme)</term><term>Immunité innée</term><term>Macrophages (immunologie)</term><term>Modèles animaux de maladie humaine</term><term>Monocytes (immunologie)</term><term>Poumon (anatomopathologie)</term><term>Poumon (immunologie)</term><term>Poumon (virologie)</term><term>Récepteurs CCR (immunologie)</term><term>Récepteurs CCR (métabolisme)</term><term>Réplication virale</term><term>Souris</term><term>Souris de lignée BALB C</term><term>Souris knockout</term><term>Statistique non paramétrique</term><term>Syndrome respiratoire aigu sévère (immunologie)</term><term>Syndrome respiratoire aigu sévère (mortalité)</term><term>Syndrome respiratoire aigu sévère (virologie)</term><term>Transduction du signal</term><term>Virus du SRAS (génétique)</term><term>Virus du SRAS (pathogénicité)</term><term>Virus du SRAS (physiologie)</term></keywords><keywords scheme="MESH" type="chemical" qualifier="genetics" xml:lang="en"><term>Myeloid Differentiation Factor 88</term></keywords><keywords scheme="MESH" type="chemical" qualifier="immunology" xml:lang="en"><term>Cytokines</term><term>Receptors, CCR</term></keywords><keywords scheme="MESH" type="chemical" qualifier="metabolism" xml:lang="en"><term>Cytokines</term><term>Myeloid Differentiation Factor 88</term><term>Receptors, CCR</term></keywords><keywords scheme="MESH" qualifier="anatomopathologie" xml:lang="fr"><term>Poumon</term></keywords><keywords scheme="MESH" qualifier="genetics" xml:lang="en"><term>SARS Virus</term></keywords><keywords scheme="MESH" qualifier="génétique" xml:lang="fr"><term>Facteur de différenciation myéloïde-88</term><term>Virus du SRAS</term></keywords><keywords scheme="MESH" qualifier="immunologie" xml:lang="fr"><term>Cytokines</term><term>Expression des gènes</term><term>Macrophages</term><term>Monocytes</term><term>Poumon</term><term>Récepteurs CCR</term><term>Syndrome respiratoire aigu sévère</term></keywords><keywords scheme="MESH" qualifier="immunology" xml:lang="en"><term>Gene Expression</term><term>Lung</term><term>Macrophages</term><term>Monocytes</term><term>Severe Acute Respiratory Syndrome</term></keywords><keywords scheme="MESH" qualifier="mortality" xml:lang="en"><term>Severe Acute Respiratory Syndrome</term></keywords><keywords scheme="MESH" qualifier="mortalité" xml:lang="fr"><term>Syndrome respiratoire aigu sévère</term></keywords><keywords scheme="MESH" qualifier="métabolisme" xml:lang="fr"><term>Cytokines</term><term>Facteur de différenciation myéloïde-88</term><term>Récepteurs CCR</term></keywords><keywords scheme="MESH" qualifier="pathogenicity" xml:lang="en"><term>SARS Virus</term></keywords><keywords scheme="MESH" qualifier="pathogénicité" xml:lang="fr"><term>Virus du SRAS</term></keywords><keywords scheme="MESH" qualifier="pathology" xml:lang="en"><term>Lung</term></keywords><keywords scheme="MESH" qualifier="physiologie" xml:lang="fr"><term>Virus du SRAS</term></keywords><keywords scheme="MESH" qualifier="physiology" xml:lang="en"><term>SARS Virus</term></keywords><keywords scheme="MESH" qualifier="virologie" xml:lang="fr"><term>Poumon</term><term>Syndrome respiratoire aigu sévère</term></keywords><keywords scheme="MESH" qualifier="virology" xml:lang="en"><term>Lung</term><term>Severe Acute Respiratory Syndrome</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Animals</term><term>Disease Models, Animal</term><term>Immunity, Innate</term><term>Mice</term><term>Mice, Inbred BALB C</term><term>Mice, Knockout</term><term>Signal Transduction</term><term>Statistics, Nonparametric</term><term>Viral Load</term><term>Virus Cultivation</term><term>Virus Replication</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>Animaux</term><term>Charge virale</term><term>Culture virale</term><term>Immunité innée</term><term>Modèles animaux de maladie humaine</term><term>Réplication virale</term><term>Souris</term><term>Souris de lignée BALB C</term><term>Souris knockout</term><term>Statistique non paramétrique</term><term>Transduction du signal</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">A novel human coronavirus, SARS-CoV, emerged suddenly in 2003, causing approximately 8000 human cases and more than 700 deaths worldwide. Since most animal models fail to faithfully recapitulate the clinical course of SARS-CoV in humans, the virus and host factors that mediate disease pathogenesis remain unclear. Recently, our laboratory and others developed a recombinant mouse-adapted SARS-CoV (rMA15) that was lethal in BALB/c mice. In contrast, intranasal infection of young 10-week-old C57BL/6 mice with rMA15 results in a nonlethal infection characterized by high titer replication within the lungs, lung inflammation, destruction of lung tissue, and loss of body weight, thus providing a useful model to identify host mediators of protection. Here, we report that mice deficient in MyD88 (MyD88(-/-)), an adapter protein that mediates Toll-like receptor (TLR), IL-1R, and IL-18R signaling, are far more susceptible to rMA15 infection. The genetic absence of MyD88 resulted in enhanced pulmonary pathology and greater than 90% mortality by day 6 post-infection. MyD88(-/-) mice had significantly higher viral loads in lung tissue throughout the course of infection. Despite increased viral loads, the expression of multiple proinflammatory cytokines and chemokines within lung tissue and recruitment of inflammatory monocytes/macrophages to the lung was severely impaired in MyD88(-/-) mice compared to wild-type mice. Furthermore, mice deficient in chemokine receptors that contribute to monocyte recruitment to the lung were more susceptible to rMA15-induced disease and exhibited severe lung pathology similar to that seen in MyD88(-/-)mice. These data suggest that MyD88-mediated innate immune signaling and inflammatory cell recruitment to the lung are required for protection from lethal rMA15 infection.</div></front></TEI><pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">19079579</PMID><DateCompleted><Year>2009</Year><Month>08</Month><Day>05</Day></DateCompleted><DateRevised><Year>2018</Year><Month>11</Month><Day>13</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1553-7374</ISSN><JournalIssue CitedMedium="Internet"><Volume>4</Volume><Issue>12</Issue><PubDate><Year>2008</Year><Month>Dec</Month></PubDate></JournalIssue><Title>PLoS pathogens</Title><ISOAbbreviation>PLoS Pathog.</ISOAbbreviation></Journal><ArticleTitle>MyD88 is required for protection from lethal infection with a mouse-adapted SARS-CoV.</ArticleTitle><Pagination><MedlinePgn>e1000240</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1371/journal.ppat.1000240</ELocationID><Abstract><AbstractText>A novel human coronavirus, SARS-CoV, emerged suddenly in 2003, causing approximately 8000 human cases and more than 700 deaths worldwide. Since most animal models fail to faithfully recapitulate the clinical course of SARS-CoV in humans, the virus and host factors that mediate disease pathogenesis remain unclear. Recently, our laboratory and others developed a recombinant mouse-adapted SARS-CoV (rMA15) that was lethal in BALB/c mice. In contrast, intranasal infection of young 10-week-old C57BL/6 mice with rMA15 results in a nonlethal infection characterized by high titer replication within the lungs, lung inflammation, destruction of lung tissue, and loss of body weight, thus providing a useful model to identify host mediators of protection. Here, we report that mice deficient in MyD88 (MyD88(-/-)), an adapter protein that mediates Toll-like receptor (TLR), IL-1R, and IL-18R signaling, are far more susceptible to rMA15 infection. The genetic absence of MyD88 resulted in enhanced pulmonary pathology and greater than 90% mortality by day 6 post-infection. MyD88(-/-) mice had significantly higher viral loads in lung tissue throughout the course of infection. Despite increased viral loads, the expression of multiple proinflammatory cytokines and chemokines within lung tissue and recruitment of inflammatory monocytes/macrophages to the lung was severely impaired in MyD88(-/-) mice compared to wild-type mice. Furthermore, mice deficient in chemokine receptors that contribute to monocyte recruitment to the lung were more susceptible to rMA15-induced disease and exhibited severe lung pathology similar to that seen in MyD88(-/-)mice. These data suggest that MyD88-mediated innate immune signaling and inflammatory cell recruitment to the lung are required for protection from lethal rMA15 infection.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Sheahan</LastName><ForeName>Timothy</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Microbiology and Immunology, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Morrison</LastName><ForeName>Thomas E</ForeName><Initials>TE</Initials></Author><Author ValidYN="Y"><LastName>Funkhouser</LastName><ForeName>William</ForeName><Initials>W</Initials></Author><Author ValidYN="Y"><LastName>Uematsu</LastName><ForeName>Satoshi</ForeName><Initials>S</Initials></Author><Author ValidYN="Y"><LastName>Akira</LastName><ForeName>Shizou</ForeName><Initials>S</Initials></Author><Author ValidYN="Y"><LastName>Baric</LastName><ForeName>Ralph S</ForeName><Initials>RS</Initials></Author><Author ValidYN="Y"><LastName>Heise</LastName><ForeName>Mark T</ForeName><Initials>MT</Initials></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>P01 AI059443</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>P01 AI59443</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2008</Year><Month>12</Month><Day>12</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>PLoS Pathog</MedlineTA><NlmUniqueID>101238921</NlmUniqueID><ISSNLinking>1553-7366</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D016207">Cytokines</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C507780">Myd88 protein, mouse</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D053594">Myeloid Differentiation Factor 88</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D054388">Receptors, CCR</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016207" MajorTopicYN="N">Cytokines</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004195" MajorTopicYN="N">Disease Models, Animal</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015870" MajorTopicYN="N">Gene Expression</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007113" MajorTopicYN="N">Immunity, Innate</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008168" MajorTopicYN="N">Lung</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008264" MajorTopicYN="N">Macrophages</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008807" MajorTopicYN="N">Mice, Inbred BALB C</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018345" MajorTopicYN="N">Mice, Knockout</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009000" MajorTopicYN="N">Monocytes</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D053594" MajorTopicYN="N">Myeloid Differentiation Factor 88</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D054388" MajorTopicYN="N">Receptors, CCR</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D045473" MajorTopicYN="N">SARS Virus</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000472" MajorTopicYN="Y">pathogenicity</QualifierName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D045169" MajorTopicYN="N">Severe Acute Respiratory Syndrome</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015398" MajorTopicYN="N">Signal Transduction</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018709" MajorTopicYN="N">Statistics, Nonparametric</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019562" MajorTopicYN="N">Viral Load</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014776" MajorTopicYN="N">Virus Cultivation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014779" MajorTopicYN="N">Virus Replication</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2008</Year><Month>06</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2008</Year><Month>11</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2008</Year><Month>12</Month><Day>17</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2008</Year><Month>12</Month><Day>17</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2009</Year><Month>8</Month><Day>6</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">19079579</ArticleId><ArticleId IdType="doi">10.1371/journal.ppat.1000240</ArticleId><ArticleId IdType="pmc">PMC2587915</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>J Immunol. 2005 Nov 15;175(10):6915-23</Citation><ArticleIdList><ArticleId IdType="pubmed">16272351</ArticleId></ArticleIdList></Reference><Reference><Citation>Immunity. 2008 Aug 15;29(2):306-17</Citation><ArticleIdList><ArticleId IdType="pubmed">18691912</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Rev Immunol. 2005 Dec;5(12):953-64</Citation><ArticleIdList><ArticleId IdType="pubmed">16322748</ArticleId></ArticleIdList></Reference><Reference><Citation>N Engl J Med. 2006 Feb 9;354(6):610-21</Citation><ArticleIdList><ArticleId IdType="pubmed">16467548</ArticleId></ArticleIdList></Reference><Reference><Citation>J Immunol. 2000 Nov 15;165(10):5392-6</Citation><ArticleIdList><ArticleId IdType="pubmed">11067888</ArticleId></ArticleIdList></Reference><Reference><Citation>Virology. 2001 Sep 15;288(1):8-17</Citation><ArticleIdList><ArticleId IdType="pubmed">11543653</ArticleId></ArticleIdList></Reference><Reference><Citation>J Immunol. 2001 Nov 15;167(10):5928-34</Citation><ArticleIdList><ArticleId IdType="pubmed">11698470</ArticleId></ArticleIdList></Reference><Reference><Citation>J Immunol. 2002 Jun 15;168(12):5997-6001</Citation><ArticleIdList><ArticleId IdType="pubmed">12055206</ArticleId></ArticleIdList></Reference><Reference><Citation>J Immunol. 2002 Oct 1;169(7):3869-75</Citation><ArticleIdList><ArticleId IdType="pubmed">12244184</ArticleId></ArticleIdList></Reference><Reference><Citation>N Engl J Med. 2003 May 15;348(20):1986-94</Citation><ArticleIdList><ArticleId IdType="pubmed">12682352</ArticleId></ArticleIdList></Reference><Reference><Citation>N Engl J Med. 2003 May 15;348(20):1953-66</Citation><ArticleIdList><ArticleId IdType="pubmed">12690092</ArticleId></ArticleIdList></Reference><Reference><Citation>Science. 2003 May 30;300(5624):1394-9</Citation><ArticleIdList><ArticleId IdType="pubmed">12730500</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet. 2003 May 24;361(9371):1767-72</Citation><ArticleIdList><ArticleId IdType="pubmed">12781535</ArticleId></ArticleIdList></Reference><Reference><Citation>JAMA. 2003 Jun 4;289(21):2801-9</Citation><ArticleIdList><ArticleId IdType="pubmed">12734147</ArticleId></ArticleIdList></Reference><Reference><Citation>CMAJ. 2003 Jun 24;168(13):1649-60</Citation><ArticleIdList><ArticleId IdType="pubmed">12821618</ArticleId></ArticleIdList></Reference><Reference><Citation>Immunity. 2003 Jul;19(1):71-82</Citation><ArticleIdList><ArticleId IdType="pubmed">12871640</ArticleId></ArticleIdList></Reference><Reference><Citation>Proc Natl Acad Sci U S A. 2003 Oct 28;100(22):12995-3000</Citation><ArticleIdList><ArticleId IdType="pubmed">14569023</ArticleId></ArticleIdList></Reference><Reference><Citation>J Leukoc Biol. 2003 Dec;74(6):1015-25</Citation><ArticleIdList><ArticleId IdType="pubmed">12972511</ArticleId></ArticleIdList></Reference><Reference><Citation>N Engl J Med. 2003 Dec 18;349(25):2431-41</Citation><ArticleIdList><ArticleId IdType="pubmed">14681510</ArticleId></ArticleIdList></Reference><Reference><Citation>Emerg Infect Dis. 2004 Jan;10(1):25-31</Citation><ArticleIdList><ArticleId IdType="pubmed">15078593</ArticleId></ArticleIdList></Reference><Reference><Citation>Clin Infect Dis. 2004 May 15;38(10):1420-7</Citation><ArticleIdList><ArticleId IdType="pubmed">15156481</ArticleId></ArticleIdList></Reference><Reference><Citation>Infect Immun. 2004 Aug;72(8):4410-5</Citation><ArticleIdList><ArticleId IdType="pubmed">15271897</ArticleId></ArticleIdList></Reference><Reference><Citation>J Immunol. 2004 Sep 15;173(6):4030-9</Citation><ArticleIdList><ArticleId IdType="pubmed">15356152</ArticleId></ArticleIdList></Reference><Reference><Citation>Cell Immunol. 1987 Apr 1;105(2):374-85</Citation><ArticleIdList><ArticleId IdType="pubmed">3568140</ArticleId></ArticleIdList></Reference><Reference><Citation>Virology. 2004 Nov 24;329(2):251-60</Citation><ArticleIdList><ArticleId IdType="pubmed">15518805</ArticleId></ArticleIdList></Reference><Reference><Citation>Eur J Immunol. 2005 Mar;35(3):822-30</Citation><ArticleIdList><ArticleId IdType="pubmed">15724245</ArticleId></ArticleIdList></Reference><Reference><Citation>J Virol. 2005 Jun;79(12):7819-26</Citation><ArticleIdList><ArticleId IdType="pubmed">15919935</ArticleId></ArticleIdList></Reference><Reference><Citation>J Exp Med. 2005 Aug 1;202(3):415-24</Citation><ArticleIdList><ArticleId IdType="pubmed">16043521</ArticleId></ArticleIdList></Reference><Reference><Citation>J Exp Med. 2005 Oct 17;202(8):1087-98</Citation><ArticleIdList><ArticleId IdType="pubmed">16230476</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS Med. 2006 Feb;3(2):e27</Citation><ArticleIdList><ArticleId IdType="pubmed">16379499</ArticleId></ArticleIdList></Reference><Reference><Citation>J Virol. 2006 May;80(9):4501-9</Citation><ArticleIdList><ArticleId IdType="pubmed">16611910</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS Med. 2006 Dec;3(12):e525</Citation><ArticleIdList><ArticleId IdType="pubmed">17194199</ArticleId></ArticleIdList></Reference><Reference><Citation>J Clin Invest. 2007 Jan;117(1):185-94</Citation><ArticleIdList><ArticleId IdType="pubmed">17200718</ArticleId></ArticleIdList></Reference><Reference><Citation>Blood. 2007 Feb 1;109(3):1131-7</Citation><ArticleIdList><ArticleId IdType="pubmed">16985170</ArticleId></ArticleIdList></Reference><Reference><Citation>J Immunol. 2007 Apr 15;178(8):5173-81</Citation><ArticleIdList><ArticleId IdType="pubmed">17404300</ArticleId></ArticleIdList></Reference><Reference><Citation>J Immunol. 2007 May 1;178(9):5820-7</Citation><ArticleIdList><ArticleId IdType="pubmed">17442966</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Rev Immunol. 2007 May;7(5):353-64</Citation><ArticleIdList><ArticleId IdType="pubmed">17457343</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS Pathog. 2007 Jan;3(1):e5</Citation><ArticleIdList><ArticleId IdType="pubmed">17222058</ArticleId></ArticleIdList></Reference><Reference><Citation>J Exp Med. 2007 Jun 11;204(6):1349-58</Citation><ArticleIdList><ArticleId IdType="pubmed">17502662</ArticleId></ArticleIdList></Reference><Reference><Citation>J Virol. 2007 Aug;81(16):8692-706</Citation><ArticleIdList><ArticleId IdType="pubmed">17537853</ArticleId></ArticleIdList></Reference><Reference><Citation>Blood. 2007 Sep 1;110(5):1578-86</Citation><ArticleIdList><ArticleId IdType="pubmed">17495130</ArticleId></ArticleIdList></Reference><Reference><Citation>J Virol. 2007 Sep;81(18):9812-24</Citation><ArticleIdList><ArticleId IdType="pubmed">17596301</ArticleId></ArticleIdList></Reference><Reference><Citation>Eur J Immunol. 2007 Sep;37(9):2434-40</Citation><ArticleIdList><ArticleId IdType="pubmed">17668900</ArticleId></ArticleIdList></Reference><Reference><Citation>J Immunol. 2007 Sep 15;179(6):3434-42</Citation><ArticleIdList><ArticleId IdType="pubmed">17785777</ArticleId></ArticleIdList></Reference><Reference><Citation>J Immunol. 2007 Oct 1;179(7):4711-20</Citation><ArticleIdList><ArticleId IdType="pubmed">17878370</ArticleId></ArticleIdList></Reference><Reference><Citation>J Leukoc Biol. 2008 Jan;83(1):64-70</Citation><ArticleIdList><ArticleId IdType="pubmed">17884993</ArticleId></ArticleIdList></Reference><Reference><Citation>Viral Immunol. 2007 Dec;20(4):599-608</Citation><ArticleIdList><ArticleId IdType="pubmed">18158733</ArticleId></ArticleIdList></Reference><Reference><Citation>J Immunol. 2008 Feb 15;180(4):2474-85</Citation><ArticleIdList><ArticleId IdType="pubmed">18250457</ArticleId></ArticleIdList></Reference><Reference><Citation>J Immunol. 2008 Feb 15;180(4):2562-72</Citation><ArticleIdList><ArticleId IdType="pubmed">18250467</ArticleId></ArticleIdList></Reference><Reference><Citation>J Virol. 2008 Mar;82(5):2274-85</Citation><ArticleIdList><ArticleId IdType="pubmed">18094188</ArticleId></ArticleIdList></Reference><Reference><Citation>Annu Rev Immunol. 2008;26:421-52</Citation><ArticleIdList><ArticleId IdType="pubmed">18303997</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS Pathog. 2008 Mar;4(3):e1000017</Citation><ArticleIdList><ArticleId IdType="pubmed">18369468</ArticleId></ArticleIdList></Reference><Reference><Citation>J Virol. 2005 Dec;79(23):14909-22</Citation><ArticleIdList><ArticleId IdType="pubmed">16282490</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></pubmed></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/SrasV1/Data/PubMed/Curation
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001995 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PubMed/Curation/biblio.hfd -nk 001995 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= SrasV1
|flux= PubMed
|étape= Curation
|type= RBID
|clé= pubmed:19079579
|texte= MyD88 is required for protection from lethal infection with a mouse-adapted SARS-CoV.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Curation/RBID.i -Sk "pubmed:19079579" \
| HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Curation/biblio.hfd \
| NlmPubMed2Wicri -a SrasV1
| This area was generated with Dilib version V0.6.33. |  |